HORSHOLM, DENMARK, November 11, 2012 (Press-News.org) Asonor is a unique solution to avoid snoring and reducing the sound during the night. This will affect millions of people, i.e. approx. 50% of the population either because they are snoring themselves (app 40%) or because they are affected as a partner. Clinical studies and market experience document that 3 out of 4 will be able to improve significantly their quality of life and health situation by taking Asonor
EXPOPHARM is the natural choice for an international meeting place for manufacturers and distributors within the pharmaceutical industry. With this in mind Danish TannerMedico A/S, the manufacturer and owner of the intellectual properties of Asonor, again selected this event for meeting with its existing distributors and importantly to meet with potential new distributors in and outside Europe.
Asonor was shown at the Danish Pavilion together with products from 6 other Danish companies. With an excellent position in Hall B5 the Danish Pavilion and Asonor enjoyed a massive interest from interested customers and distributors.
Asonor scored highly at the biggest ever anti-snoring user test in Europe, according to reports from the Swedish organization Buzzador arranging this test performed by 1.000 men and woman with serious snoring problems. Impressive 66% did say that they find Asonor, anti-snoring solution better than other snoring products that they have used in the past.
TannerMedico manufacture and internationally distribute Asonor snore relief. Asonor is one of the world's leading products in snore treatment, studied and clinically proven in London and Copenhagen. Read also the latest news about sleep apnea and sleep disorders on www.asonor.com. For further information, please contact us at info@tannermedico.com.
Massive Interest for Asonor Anti-Snoring Solution at Expopharm '12 in Munich Germany
Asonor was exhibited to the German pharmacies under the slogan: "Deutschland schlaft durch!" - Germany sleeps through the night!
2012-11-11
ELSE PRESS RELEASES FROM THIS DATE:
Online Pawnshop, PawnUp.com, Takes the Royal Cake with Winning Auction Bid
2012-11-11
PawnUp.com served up a total of $7100 today at an auction held by Julien's Auctions of Beverly Hills. The first bid was placed on a slice of cake from the wedding of the Prince and Princess of Wales who were famously united in 1981. While the cake is no longer suitable for human consumption, it was still expected to fetch between $1000 and $2000. It ultimately sold for $1100. In a surprising twist, the winning bid for the brandy-infused slice of wedding cake from the union of Prince William to Kate Middleton was estimated to be between $600 and $800, and yet the winning ...
Rheumatoid arthritis patients can get gout too, Mayo Clinic Study finds
2012-11-11
WASHINGTON -- Refuting a belief long held by many physicians, a Mayo Clinic study found that rheumatoid arthritis patients also can get gout. The research is among several studies Mayo Clinic is presenting at the American College of Rheumatology annual meeting in Washington. Researchers also found that gut bacteria has potential to treat autoimmune disorders, rheumatoid arthritis patients are at higher risk for cancer, broken bones put rheumatoid arthritis patients in greater danger of heart disease and death, and corticosteroids are a mainstay of rheumatoid arthritis treatment ...
Lower-income patients fare better than wealthier after knee replacement, mayo finds
2012-11-11
WASHINGTON -- Patients who make $35,000 a year or less report better outcomes after knee replacement surgery than people who earn more, research by Mayo Clinic and the University of Alabama at Birmingham shows. The lower-income patients studied reported less pain and better knee function at their two-year checkups than wealthier people did. The study was being presented at the American College of Rheumatology annual meeting in Washington.
VIDEO ALERT: A video interview with Dr. Lewallen is available for journalists to download
on the Mayo Clinic News Network.
The ...
Study overturns common assumption about knee replacements in morbidly obese individuals
2012-11-11
After total knee replacement (TKR) surgery, patients who are morbidly obese have similar pain and function outcomes as patients who do not fall into this weight category, according to a new study by researchers at Hospital for Special Surgery. The finding is surprising given that numerous studies have shown that obese patients have worse outcomes. The study will be reported at the annual meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals, to be held Nov. 9-14, in Washington D.C.
"As long as they are medically appropriate for ...
Researchers identify impact of rheumatoid arthritis and lupus on joint replacement surgery outcomes
2012-11-11
Two new studies by researchers at Hospital for Special Surgery have overturned common beliefs about joint replacement in patients with lupus and rheumatoid arthritis (RA).
In one study, researchers demonstrated that RA patients who undergo a knee replacement can expect outcomes that are similar to individuals undergoing the operation for osteoarthritis. In the other, investigators showed that lupus patients undergoing joint replacement surgery experienced far fewer adverse events than previously thought. The news will be reported at the annual meeting of the American ...
Hospital-based exercise programs benefit people with osteoarthritis
2012-11-11
A low-cost exercise program run by Hospital for Special Surgery in New York City has significantly improved pain, function and quality of life in participants with osteoarthritis, according to new research.
The study adds to the growing evidence that exercise is beneficial for osteoarthritis and shows that a hospital-based program can work. The study will be reported at the annual meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP), to be held Nov. 9-14, in Washington D.C.
The new study showed that the weekly ...
Expensive arthritis treatment no better than steroid therapy
2012-11-11
A randomized, double-blind clinical trial by researchers at Hospital for Special Surgery has revealed that corticosteroids are more effective than the more expensive treatment, hylan G-F 20 (Synvisc One, Genzyme Biosurgery), in providing pain relief to patients with thumb arthritis. The study also showed that both of these commonly used treatments provided clinically meaningful pain relief, but so did a placebo injection.
"On average, each of the therapies resulted in clinically meaningful improvement in pain," said Lisa Mandl, M.D., MPH, a rheumatologist at Hospital ...
Autoimmune disease linked to pregnancy loss, stroke more often than you’d expect
2012-11-11
For years, researchers have known that antiphospholipid antibodies (aPLs) can cause pregnancy loss and clotting, but they haven't known the true scope of the problem. Now a new study provides the first estimates of the prevalence of these antibodies in patients suffering from pregnancy loss, stroke, myocardial infarction, and deep vein thrombosis.
"Based on the available data, our best estimate is that around 10 to 15% of clotting disorders are associated with autoimmune antiphospholipid antibodies," said Doruk Erkan, M.D., an associate attending rheumatologist and clinician ...
Statins have potential to treat an autoimmune clotting disorder called antiphospholipid syndrome
2012-11-11
New research suggests that statins, traditionally used for cholesterol lowering, could be used in the management of individuals who are at risk for developing clotting because they have autoimmune antiphospholipid antibodies (aPL). The research will be presented in two presentations at the annual meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP). The meeting will be held Nov. 9-14, in Washington D.C.
"What we have shown is that inflammatory and thrombotic proteins are elevated in aPL-positive patients and that ...
New York Plantings Garden Design Kickoffs With Their Latest Garden Designer's Process
2012-11-11
New York Plantings, the leading garden designer and landscape contractors, had just recently done two garden designs for terrace and rooftop gardens in New York City, one in 37 West, 12th St., Manhattan, NYC and another at 618 Dean St., Brooklyn, NYC. With these projects, New York Plantings Garden Designers and Landscape Contractors have utilized another process for their business using their new landscape and garden designer's software- 3D rendering.
As New York Plantings Garden Designers and Landscape Contractors offers a wide range of services, they also have a tedious ...
LAST 30 PRESS RELEASES:
Half-billion-year-old parasite still threatens shellfish
Engineering a clearer view of bone healing
Detecting heart issues in breast cancer survivors
Moffitt study finds promising first evidence of targeted therapy for NRAS-mutant melanoma
Lay intuition as effective at jailbreaking AI chatbots as technical methods
USC researchers use AI to uncover genetic blueprint of the brain’s largest communication bridge
Tiny swarms, big impact: Researchers engineering adaptive magnetic systems for medicine, energy and environment
MSU study: How can AI personas be used to detect human deception?
Slowed by sound: A mouse model of Parkinson’s Disease shows noise affects movement
Demographic shifts could boost drug-resistant infections across Europe
Insight into how sugars regulate the inflammatory disease process
PKU scientists uncover climate impacts and future trends of hailstorms in China
Computer model mimics human audiovisual perception
AC instead of DC: A game-changer for VR headsets and near-eye displays
Prevention of cardiovascular disease events and deaths among black adults via systolic blood pressure equity
Facility-based uptake of colorectal cancer screening in 45- to 49-year-olds after US guideline changes
Scientists uncover hidden nuclear droplets that link multiple leukemias and reveal a new therapeutic target
A new patch could help to heal the heart
New study shows people with spinal cord injuries are more likely to develop chronic disorders
Heat as a turbo-boost for immune cells
Jülich researchers reveal: Long-lived contrails usually form in natural ice clouds
Controlling next-generation energy conversion materials with simple pressure
More than 100,000 Norwegians suffer from work-related anxiety
The American Pediatric Society selects Dr. Harolyn Belcher as the recipient of the 2026 David G. Nichols Health Equity Award
Taft Armandroff and Brian Schmidt elected to lead Giant Magellan Telescope Board of Directors
FAU Engineering receives $1.5m gift to launch the ‘Ubicquia Innovation Center for Intelligent Infrastructure’
Japanese public show major reservations to cell donation for human brain organoid research
NCCN celebrates expanding access to cancer treatment in Africa at 2025 AORTIC Meeting with new NCCN adaptations for Sub-Saharan Africa
Three health tech innovators recognized for digital solutions to transform cardiovascular care
A sequence of human rights violations precedes mass atrocities, new research shows
[Press-News.org] Massive Interest for Asonor Anti-Snoring Solution at Expopharm '12 in Munich GermanyAsonor was exhibited to the German pharmacies under the slogan: "Deutschland schlaft durch!" - Germany sleeps through the night!